4//SEC Filing
Tutewohl Steve 4
Accession 0001628908-22-000007
CIK 0001628908other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 5:40 PM ET
Size
9.2 KB
Accession
0001628908-22-000007
Insider Transaction Report
Form 4
Tutewohl Steve
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-02-01$13.95/sh+6,313$88,066→ 106,863 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2022-02-01−6,313→ 0 totalExercise: $13.95Exp: 2028-02-01→ Class A Common Stock (6,313 underlying) - Sale
Class A Common Stock
2022-02-01$23.47/sh−6,313$148,166→ 100,550 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.80, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The Class A Common Stock Options exercised vested on February 1, 2022.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001811845
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 5:40 PM ET
- Size
- 9.2 KB